Prices of Some Key Drugs to Go Down in India

by Gopalan on July 7, 2009 at 1:04 PM
 Prices of Some Key Drugs to Go Down in India

Prices of cancer, cardiac, hepatitis, and arthritis could go down in India in the wake of the budget proposals of Monday.

The federal Finance Minister announced lowering of customs duty on as many as nine specified drugs, mainly biologics, used in treatment of cancer, HIV, hepatitis-B, arthritis drugs and two life-saving cardiac devices.


The reduction ranges from ten per cent to five per cent on medicines and bulk drugs, and from 7.5 per cent to five per cent on devices.

Also, Piramal healthcare Director Swati Pirmal noted, "Excise duty remaining at four per cent and implementation of GST should reduce transaction costs, and the patients should stand to benefit ultimately."

However, the pharmaceutical and healthcare industry expressed their disappointment, saying their demands for tax incentives for R&D have been ignored. "The pharma industry has neither gained anything and nor lost anything in the Budget, there is nothing in it for us to celebrate," said  Indian Drug Manufacturer Association Executive Director Gajanan Wakankar.

Fortis Healthcare Managing Director and Chief Executive Officer Shivinder Mohan Singh said, "Healthcare sector has been ignored. We had been expecting a boost for the healthcare infrastructure, but nothing has been said on it. Budget was mute.
We are disappointed."

However, reduction of customs duty and zero excise duty on certain medical device is likely to rationalize the cost of treatment of heart ailments. The devices are generally expensive for a large size population suffering from heart ailments in India, and hence rationalization should make the devices that much cheaper, said Ernst & Young Partner and National Leader, Health Sciences Practice, Hitesh Sharma said.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Corporate News

 Global Report of Work-related Diseases
The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.
New AI Tool Could Ensure Smooth Job Transitions
Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.
 Recent Improvements In Pharmaceutical Sector
AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
Food to be Covered by Insurance Soon
Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.
Pharma Companies Have to Support or Risk Damaging Global Reputation
Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Prices of Some Key Drugs to Go Down in India Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests